{"id":81,"date":"2014-11-19T02:08:34","date_gmt":"2014-11-19T02:08:34","guid":{"rendered":""},"modified":"2017-07-01T06:21:46","modified_gmt":"2017-07-01T06:21:46","slug":"zimmer-nexgen-knee","status":"publish","type":"page","link":"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/","title":{"rendered":"Zimmer NexGen Knee"},"content":{"rendered":"<h3>Zimmer Knee Cases<\/h3>\n<p><img decoding=async  class=\"alignright\" src=\"https:\/\/mltmpgeox6sf.i.optimole.com\/snoNFDk.o-Mv~1ec23\/w:auto\/h:auto\/q:mauto\/f:avif\/https:\/\/www.lawsuitsettlementnews.com\/wp-content\/uploads\/description\/zimmer-knee-lawyer.jpg\" alt=\"zimmer-knee-lawyer\" height=\"250\" width=\"400\" \/><\/p>\n<p>MT Services LLC provides up-to-date lawsuit news on the Zimmer Knee cases and resulting multidistrict litigation as well as various services to assist victims with getting the help they need during this difficult time. These services include: Lawsuit Pre-Settlement Funding Cash Advances, Surgical or Medical Procedure Funding (or cash needs related to surgery), and Attorney Referrals to nationally recognized Zimmer Knee lawyers and law firms.<\/p>\n<h4>Zimmer Persona Knee Cases\/FDA Class II Recall<\/h4>\n<p>The FDA announced a Class II recall for Zimmer\u2019s Persona Trabecular Metal Tibial Plate knee implant. The recall affects all lots and sizes of the knee implant, affecting all 11,658 devices that were recalled, according to the FDA\u2019s website. Also, according to an announcement made by the FDA, they said Zimmer Inc. initiated a voluntary recall of their Persona Trabecular Metal Tibial after there was an increase in complaints of loosening and radiolucent lines. All sizes and lots of the affected devices will be removed from the market and will no longer be distributed. A Class II Recall occurs when a product can \"cause temporary or medically reversible adverse health consequences.\" Patients who have been implanted with the Persona Trabecular Metal Tibial Plate face the risk of their tibialcomponent loosening. Indications of this complication include radiolucent lines on imaging tests, and such loosening may cause pain and issues with mobility, often requiring the patient to have an additional surgery.<\/p>\n<h4>Possible Side Effects<\/h4>\n<p>Radiolucent lines \u2013 \u201clarge gaps in between knee replacement components or between the components and the bone\u201d \u2013 can lead to a several different problems such as:<\/p>\n<ul>\n<li>Joint fluid<\/li>\n<li>Tissue damage<\/li>\n<li>Osteolysis &nbsp;<\/li>\n<li>Severe pain<\/li>\n<li>Swelling<\/li>\n<li>Bone damage<\/li>\n<\/ul>\n<h4>FDA Issues Recalls to Zimmer Inc. NextGen Knee<\/h4>\n<p>In 2010, the U.S. Food &amp; Drug Administration issued a Class II recall to Zimmer Inc. over the NexGen Complete Knee Solution MIS Tibial Components, Locking Screw and Stem Extensions, affecting 68,383 devices that had already been implanted. Recalls were issued for various components of the NexGen knee mechanisms (the NexGen LPS femoral component, the NexGen LPS Flex gender femoral component, and the NexGen MIS tibial components).<\/p>\n<p>An FDA Class II recall typically indicates that a device may cause \u201ctemporary or medically reversible\u201d health problems, as well as a remote possibility of serious health problems.<\/p>\n<p>In addition to the FDA Class II recall, a voluntary recall was made by Zimmer Inc., regarding the NexGen MIS Tibial Component, because according to drug watch, \u201cone of the pieces could loosen or fail because of shoddy manufacturing.\u201d The voluntary recall that was initiated affects 41,180 devices and includes eight sizes (1-8).<\/p>\n<h4>Zimmer Recalls affect over 100K devices<\/h4>\n<p>According to MT Services, the recalls that were made on various devices affect over 100K devices. The NexGen Flex devices have been implanted in approximately 150K patients, and today, there are over 1,000 lawsuits filed against Zimmer Inc. in state and federal courts throughout the U.S. The initial trial date is set for February 2015.<\/p>\n<p>Federal lawsuits have been consolidated into multidistrict litigation (MDL) in the U.S. District Court in the North District of Illinois, with the first bellwether trial set to begin in 2015.<\/p>\n<p>The devices were meant to increase range of motion and imitate natural knee function, but plaintiffs who have filed cases against Zimmer Inc. claim that the devices actually caused a range of complications.<\/p>\n<p>Some of the injuries include:<\/p>\n<ul>\n<li>Decreased range of motion<\/li>\n<li>Extreme pain<\/li>\n<li>Tissue and\/or nerve damage<\/li>\n<li>Bone degradation or fractures<\/li>\n<li>Instability<\/li>\n<li>Infection<\/li>\n<li>Blood clots\/li>\n<li>Ultimate failure of device implant<\/li>\n<\/ul>\n<h4>First Zimmer NexGen Knee Bellwether Trial Approaching<\/h4>\n<p>The first bellwether trial in the multidistrict litigation (MDL) over the Zimmer NexGen Knee implant lawsuits has been scheduled to begin October 13th, 2015. There are currently more than a thousand cases against Zimmer Inc.which have been consolidated before a federal judge in Illinois (In Re: Zimmer NexGen Knee Implant Products Liability Litigation, MDL No. 2272).<\/p>\n<p><strong>If you, or a loved one, believe that you have suffered any injuries from a Zimmer Knee implant and need to speak with a nationally recognized Zimmer Knee law firm, fill out the application on the upper right hand part of this page or call MT Services\u2019 toll free hotline at: 877.571.0405 where live agents can assist you with any lawsuit services that you may need.<\/strong><\/p>\n<p><strong>Please read our Disclosure Statement located on the footer of our website which outlines the terms and conditions regarding our various vendor relationships.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p><span style=\"font-size: 18pt; font-family: helvetica; color: #0000ff;\">Zimmer Knee Cases<\/span><\/p>\n<p><img decoding=async  src=\"https:\/\/mltmpgeox6sf.i.optimole.com\/snoNFDk.o-Mv~1ec23\/w:auto\/h:auto\/q:mauto\/f:avif\/https:\/\/www.lawsuitsettlementnews.com\/wp-content\/uploads\/description\/zimmer-knee-lawyer.jpg\" alt=\"zimmer-knee-lawyer\" style=\"margin: 1px; float: right;\" height=\"250\" width=\"400\" \/>MT Services LLC provides up-to-date lawsuit news on the Zimmer Knee cases and resulting multidistrict litigation as well as various services to assist victims with getting the help they need during this difficult time. These services include: Lawsuit Pre-Settlement Funding Cash Advances, Surgical or Medical Procedure Funding (or cash needs related to surgery), and Attorney Referrals to nationally recognized Zimmer Knee lawyers and law firms.<\/p>\n<h4><span style=\"color: #0000ff;\">Zimmer Persona Knee Cases\/FDA Class II Recall<\/span><\/h4>\n<p>The FDA announced a Class II recall for Zimmer\u2019s Persona Trabecular Metal Tibial Plate knee implant. The recall affects all lots and sizes of the knee implant, affecting all 11,658 devices that were recalled, according to the FDA\u2019s website. Also, according to an announcement made by the FDA, they said Zimmer Inc. initiated a voluntary recall of their Persona Trabecular Metal Tibial after there was an increase in complaints of loosening and radiolucent lines. All sizes and lots of the affected devices will be removed from the market and will no longer be distributed. A Class II Recall occurs when a product can \"cause temporary or medically reversible adverse health consequences.\" Patients who have been implanted with the Persona Trabecular Metal Tibial Plate face the risk of their tibialcomponent loosening. Indications of this complication include radiolucent lines on imaging tests, and such loosening may cause pain and issues with mobility, often requiring the patient to have an additional surgery.<\/p>\n<h4><span style=\"color: #0000ff;\">Possible Side Effects<\/span><\/h4>\n<p>Radiolucent lines \u2013 \u201clarge gaps in between knee replacement components or between the components and the bone\u201d \u2013 can lead to a several different problems such as:<\/p>\n<ul>\n<li><span style=\"color: #000000;\"><strong>Joint fluid<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\"><strong>Tissue damage<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\"><strong>Osteolysis &nbsp;<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\"><strong>Severe pain<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\"><strong>Swelling<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\"><strong>Bone damage<\/strong><\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h4><span style=\"color: #0000ff;\">FDA Issues Recalls to Zimmer Inc. NextGen Knee<br \/><\/span><\/h4>\n<p>In 2010, the U.S. Food &amp; Drug Administration issued a Class II recall to Zimmer Inc. over the NexGen Complete Knee Solution MIS Tibial Components, Locking Screw and Stem Extensions, affecting 68,383 devices that had already been implanted. Recalls were issued for various components of the NexGen knee mechanisms (the NexGen LPS femoral component, the NexGen LPS Flex gender femoral component, and the NexGen MIS tibial components).<\/p>\n<p>An FDA Class II recall typically indicates that a device may cause \u201ctemporary or medically reversible\u201d health problems, as well as a remote possibility of serious health problems.<\/p>\n<p>In addition to the FDA Class II recall, a voluntary recall was made by Zimmer Inc., regarding the NexGen MIS Tibial Component, because according to drug watch, \u201cone of the pieces could loosen or fail because of shoddy manufacturing.\u201d The voluntary recall that was initiated affects 41,180 devices and includes eight sizes (1-8).<\/p>\n<p>&nbsp;<\/p>\n<h4><span style=\"color: #0000ff;\">Zimmer Recalls affect over 100K devices<\/span><\/h4>\n<p>According to MT Services, the recalls that were made on various devices affect over 100K devices. The NexGen Flex devices have been implanted in approximately 150K patients, and today, there are over 1,000 lawsuits filed against Zimmer Inc. in state and federal courts throughout the U.S. The initial trial date is set for February 2015.<\/p>\n<p>Federal lawsuits have been consolidated into multidistrict litigation (MDL) in the U.S. District Court in the North District of Illinois, with the first bellwether trial set to begin in 2015.<\/p>\n<p>The devices were meant to increase range of motion and imitate natural knee function, but plaintiffs who have filed cases against Zimmer Inc. claim that the devices actually caused a range of complications.<\/p>\n<p>Some of the injuries include:<\/p>\n<ul>\n<li><span style=\"color: #000000;\"><strong>Decreased range of motion<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\"><strong>Extreme pain<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\"><strong>Tissue and\/or nerve damage<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\"><strong>Bone degradation or fractures<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\"><strong>Instability<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\"><strong>Infection<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\"><strong>Blood clots<\/strong><\/span><\/li>\n<li><span style=\"color: #000000;\"><strong>Ultimate failure of device implant<\/strong><\/span><\/li>\n<\/ul>\n<p><span style=\"color: #000000;\"><strong>&nbsp;<\/strong><\/span><\/p>\n<h4><span style=\"color: #0000ff;\">First Zimmer NexGen Knee Bellwether Trial Approaching<\/span><\/h4>\n<p>The first bellwether trial in the multidistrict litigation (MDL) over the Zimmer NexGen Knee implant lawsuits has been scheduled to begin October 13th, 2015. There are currently more than a thousand cases against Zimmer Inc.which have been consolidated before a federal judge in Illinois (In Re: Zimmer NexGen Knee Implant Products Liability Litigation, MDL No. 2272).<\/p>\n<p><span style=\"color: #000000;\"><b>If you, or a loved one, believe that you have suffered any injuries from a Zimmer Knee implant and need to speak with a nationally recognized Zimmer Knee law firm, fill out the application on the upper right hand part of this page or call MT Services\u2019 toll free hotline at: 877.571.0405 where live agents can assist you with any lawsuit services that you may need.<\/b><\/span><\/p>\n<p><span style=\"color: #000000;\"><strong>Please read our Disclosure Statement located on the footer of our website which outlines the terms and conditions regarding our various vendor relationships.<\/strong><\/span><\/p>\n<p> <\/p>\n","protected":false},"author":2,"featured_media":0,"parent":40,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Zimmer NexGen Knee - Lawsuit Settlement News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zimmer NexGen Knee - Lawsuit Settlement News\" \/>\n<meta property=\"og:description\" content=\"Zimmer Knee Cases MT Services LLC provides up-to-date lawsuit news on the Zimmer Knee cases and resulting multidistrict litigation as well as various services to assist victims with getting the help they need during this difficult time. These services include: Lawsuit Pre-Settlement Funding Cash Advances, Surgical or Medical Procedure Funding (or cash needs related to surgery), and Attorney Referrals to nationally recognized Zimmer Knee lawyers and law firms. Zimmer Persona Knee Cases\/FDA Class II Recall The FDA announced a Class II recall for Zimmer\u2019s Persona Trabecular Metal Tibial Plate knee implant. The recall affects all lots and sizes of the knee implant, affecting all 11,658 devices that were recalled, according to the FDA\u2019s website. Also, according to an announcement made by the FDA, they said Zimmer Inc. initiated a voluntary recall of their Persona Trabecular Metal Tibial after there was an increase in complaints of loosening and radiolucent lines. All sizes and lots of the affected devices will be removed from the market and will no longer be distributed. A Class II Recall occurs when a product can &quot;cause temporary or medically reversible adverse health consequences.&quot; Patients who have been implanted with the Persona Trabecular Metal Tibial Plate face the risk of their tibialcomponent loosening. Indications of this complication include radiolucent lines on imaging tests, and such loosening may cause pain and issues with mobility, often requiring the patient to have an additional surgery. Possible Side Effects Radiolucent lines \u2013 \u201clarge gaps in between knee replacement components or between the components and the bone\u201d \u2013 can lead to a several different problems such as:  Joint fluid Tissue damage Osteolysis &nbsp; Severe pain Swelling Bone damage  &nbsp; FDA Issues Recalls to Zimmer Inc. NextGen Knee In 2010, the U.S. Food &amp; Drug Administration issued a Class II recall to Zimmer Inc. over the NexGen Complete Knee Solution MIS Tibial Components, Locking Screw and Stem Extensions, affecting 68,383 devices that had already been implanted. Recalls were issued for various components of the NexGen knee mechanisms (the NexGen LPS femoral component, the NexGen LPS Flex gender femoral component, and the NexGen MIS tibial components). An FDA Class II recall typically indicates that a device may cause \u201ctemporary or medically reversible\u201d health problems, as well as a remote possibility of serious health problems. In addition to the FDA Class II recall, a voluntary recall was made by Zimmer Inc., regarding the NexGen MIS Tibial Component, because according to drug watch, \u201cone of the pieces could loosen or fail because of shoddy manufacturing.\u201d The voluntary recall that was initiated affects 41,180 devices and includes eight sizes (1-8). &nbsp; Zimmer Recalls affect over 100K devices According to MT Services, the recalls that were made on various devices affect over 100K devices. The NexGen Flex devices have been implanted in approximately 150K patients, and today, there are over 1,000 lawsuits filed against Zimmer Inc. in state and federal courts throughout the U.S. The initial trial date is set for February 2015. Federal lawsuits have been consolidated into multidistrict litigation (MDL) in the U.S. District Court in the North District of Illinois, with the first bellwether trial set to begin in 2015. The devices were meant to increase range of motion and imitate natural knee function, but plaintiffs who have filed cases against Zimmer Inc. claim that the devices actually caused a range of complications. Some of the injuries include:  Decreased range of motion Extreme pain Tissue and\/or nerve damage Bone degradation or fractures Instability Infection Blood clots Ultimate failure of device implant  &nbsp; First Zimmer NexGen Knee Bellwether Trial Approaching The first bellwether trial in the multidistrict litigation (MDL) over the Zimmer NexGen Knee implant lawsuits has been scheduled to begin October 13th, 2015. There are currently more than a thousand cases against Zimmer Inc.which have been consolidated before a federal judge in Illinois (In Re: Zimmer NexGen Knee Implant Products Liability Litigation, MDL No. 2272). If you, or a loved one, believe that you have suffered any injuries from a Zimmer Knee implant and need to speak with a nationally recognized Zimmer Knee law firm, fill out the application on the upper right hand part of this page or call MT Services\u2019 toll free hotline at: 877.571.0405 where live agents can assist you with any lawsuit services that you may need. Please read our Disclosure Statement located on the footer of our website which outlines the terms and conditions regarding our various vendor relationships.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/\" \/>\n<meta property=\"og:site_name\" content=\"Lawsuit Settlement News\" \/>\n<meta property=\"article:modified_time\" content=\"2017-07-01T06:21:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mltmpgeox6sf.i.optimole.com\/snoNFDk.o-Mv~1ec23\/w:auto\/h:auto\/q:mauto\/f:avif\/https:\/\/www.lawsuitsettlementnews.com\/wp-content\/uploads\/description\/zimmer-knee-lawyer.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/#website\",\"url\":\"https:\/\/www.lawsuitsettlementnews.com\/\",\"name\":\"Lawsuit Settlement News\",\"description\":\"Mass Tort Services LLC\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lawsuitsettlementnews.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/#primaryimage\",\"url\":\"https:\/\/mltmpgeox6sf.i.optimole.com\/snoNFDk.o-Mv~1ec23\/w:auto\/h:auto\/q:mauto\/f:avif\/https:\/\/www.lawsuitsettlementnews.com\/wp-content\/uploads\/description\/zimmer-knee-lawyer.jpg\",\"contentUrl\":\"https:\/\/mltmpgeox6sf.i.optimole.com\/snoNFDk.o-Mv~1ec23\/w:auto\/h:auto\/q:mauto\/f:avif\/https:\/\/www.lawsuitsettlementnews.com\/wp-content\/uploads\/description\/zimmer-knee-lawyer.jpg\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/\",\"url\":\"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/\",\"name\":\"Zimmer NexGen Knee - Lawsuit Settlement News\",\"isPartOf\":{\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/#primaryimage\"},\"datePublished\":\"2014-11-19T02:08:34+00:00\",\"dateModified\":\"2017-07-01T06:21:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.lawsuitsettlementnews.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Defective Product Lawsuits\",\"item\":\"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Zimmer NexGen Knee\"}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zimmer NexGen Knee - Lawsuit Settlement News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/","og_locale":"en_US","og_type":"article","og_title":"Zimmer NexGen Knee - Lawsuit Settlement News","og_description":"Zimmer Knee Cases MT Services LLC provides up-to-date lawsuit news on the Zimmer Knee cases and resulting multidistrict litigation as well as various services to assist victims with getting the help they need during this difficult time. These services include: Lawsuit Pre-Settlement Funding Cash Advances, Surgical or Medical Procedure Funding (or cash needs related to surgery), and Attorney Referrals to nationally recognized Zimmer Knee lawyers and law firms. Zimmer Persona Knee Cases\/FDA Class II Recall The FDA announced a Class II recall for Zimmer\u2019s Persona Trabecular Metal Tibial Plate knee implant. The recall affects all lots and sizes of the knee implant, affecting all 11,658 devices that were recalled, according to the FDA\u2019s website. Also, according to an announcement made by the FDA, they said Zimmer Inc. initiated a voluntary recall of their Persona Trabecular Metal Tibial after there was an increase in complaints of loosening and radiolucent lines. All sizes and lots of the affected devices will be removed from the market and will no longer be distributed. A Class II Recall occurs when a product can \"cause temporary or medically reversible adverse health consequences.\" Patients who have been implanted with the Persona Trabecular Metal Tibial Plate face the risk of their tibialcomponent loosening. Indications of this complication include radiolucent lines on imaging tests, and such loosening may cause pain and issues with mobility, often requiring the patient to have an additional surgery. Possible Side Effects Radiolucent lines \u2013 \u201clarge gaps in between knee replacement components or between the components and the bone\u201d \u2013 can lead to a several different problems such as:  Joint fluid Tissue damage Osteolysis &nbsp; Severe pain Swelling Bone damage  &nbsp; FDA Issues Recalls to Zimmer Inc. NextGen Knee In 2010, the U.S. Food &amp; Drug Administration issued a Class II recall to Zimmer Inc. over the NexGen Complete Knee Solution MIS Tibial Components, Locking Screw and Stem Extensions, affecting 68,383 devices that had already been implanted. Recalls were issued for various components of the NexGen knee mechanisms (the NexGen LPS femoral component, the NexGen LPS Flex gender femoral component, and the NexGen MIS tibial components). An FDA Class II recall typically indicates that a device may cause \u201ctemporary or medically reversible\u201d health problems, as well as a remote possibility of serious health problems. In addition to the FDA Class II recall, a voluntary recall was made by Zimmer Inc., regarding the NexGen MIS Tibial Component, because according to drug watch, \u201cone of the pieces could loosen or fail because of shoddy manufacturing.\u201d The voluntary recall that was initiated affects 41,180 devices and includes eight sizes (1-8). &nbsp; Zimmer Recalls affect over 100K devices According to MT Services, the recalls that were made on various devices affect over 100K devices. The NexGen Flex devices have been implanted in approximately 150K patients, and today, there are over 1,000 lawsuits filed against Zimmer Inc. in state and federal courts throughout the U.S. The initial trial date is set for February 2015. Federal lawsuits have been consolidated into multidistrict litigation (MDL) in the U.S. District Court in the North District of Illinois, with the first bellwether trial set to begin in 2015. The devices were meant to increase range of motion and imitate natural knee function, but plaintiffs who have filed cases against Zimmer Inc. claim that the devices actually caused a range of complications. Some of the injuries include:  Decreased range of motion Extreme pain Tissue and\/or nerve damage Bone degradation or fractures Instability Infection Blood clots Ultimate failure of device implant  &nbsp; First Zimmer NexGen Knee Bellwether Trial Approaching The first bellwether trial in the multidistrict litigation (MDL) over the Zimmer NexGen Knee implant lawsuits has been scheduled to begin October 13th, 2015. There are currently more than a thousand cases against Zimmer Inc.which have been consolidated before a federal judge in Illinois (In Re: Zimmer NexGen Knee Implant Products Liability Litigation, MDL No. 2272). If you, or a loved one, believe that you have suffered any injuries from a Zimmer Knee implant and need to speak with a nationally recognized Zimmer Knee law firm, fill out the application on the upper right hand part of this page or call MT Services\u2019 toll free hotline at: 877.571.0405 where live agents can assist you with any lawsuit services that you may need. Please read our Disclosure Statement located on the footer of our website which outlines the terms and conditions regarding our various vendor relationships.","og_url":"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/","og_site_name":"Lawsuit Settlement News","article_modified_time":"2017-07-01T06:21:46+00:00","og_image":[{"url":"https:\/\/mltmpgeox6sf.i.optimole.com\/snoNFDk.o-Mv~1ec23\/w:auto\/h:auto\/q:mauto\/f:avif\/https:\/\/www.lawsuitsettlementnews.com\/wp-content\/uploads\/description\/zimmer-knee-lawyer.jpg"}],"twitter_card":"summary","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/www.lawsuitsettlementnews.com\/#website","url":"https:\/\/www.lawsuitsettlementnews.com\/","name":"Lawsuit Settlement News","description":"Mass Tort Services LLC","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lawsuitsettlementnews.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/#primaryimage","url":"https:\/\/mltmpgeox6sf.i.optimole.com\/snoNFDk.o-Mv~1ec23\/w:auto\/h:auto\/q:mauto\/f:avif\/https:\/\/www.lawsuitsettlementnews.com\/wp-content\/uploads\/description\/zimmer-knee-lawyer.jpg","contentUrl":"https:\/\/mltmpgeox6sf.i.optimole.com\/snoNFDk.o-Mv~1ec23\/w:auto\/h:auto\/q:mauto\/f:avif\/https:\/\/www.lawsuitsettlementnews.com\/wp-content\/uploads\/description\/zimmer-knee-lawyer.jpg"},{"@type":"WebPage","@id":"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/","url":"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/","name":"Zimmer NexGen Knee - Lawsuit Settlement News","isPartOf":{"@id":"https:\/\/www.lawsuitsettlementnews.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/#primaryimage"},"datePublished":"2014-11-19T02:08:34+00:00","dateModified":"2017-07-01T06:21:46+00:00","breadcrumb":{"@id":"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/zimmer-nexgen-knee\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lawsuitsettlementnews.com\/"},{"@type":"ListItem","position":2,"name":"Defective Product Lawsuits","item":"https:\/\/www.lawsuitsettlementnews.com\/defective-product\/"},{"@type":"ListItem","position":3,"name":"Zimmer NexGen Knee"}]}]}},"_links":{"self":[{"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/pages\/81"}],"collection":[{"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/comments?post=81"}],"version-history":[{"count":0,"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/pages\/81\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/pages\/40"}],"wp:attachment":[{"href":"https:\/\/www.lawsuitsettlementnews.com\/wp-json\/wp\/v2\/media?parent=81"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}